Celcuity Inc.: Form 10-Q for the period ended Sep 30, 2021
Filed with the SEC on Nov 9, 2021 and accepted by EDGAR at Nov 9, 2021, 13:00 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2021-07-01 to 2021-09-30 | $5.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2021-01-01 to 2021-09-30 | $20.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2021-07-01 to 2021-09-30 | −$5.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2021-01-01 to 2021-09-30 | −$22.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2021-07-01 to 2021-09-30 | $433.1k | us-gaap:InterestExpense |
| Interest expense | 9 months2021-01-01 to 2021-09-30 | $824.3k | us-gaap:InterestExpense |
| Net income | 3 months2021-07-01 to 2021-09-30 | −$6.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2021-01-01 to 2021-09-30 | −$22.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-07-01 to 2021-09-30 | −$0.41 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2021-01-01 to 2021-09-30 | −$1.78 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months2021-01-01 to 2021-09-30 | −$14.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2021-01-01 to 2021-09-30 | $72.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2021-09-30 | $90.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-09-30 | $91.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-09-30 | $91.8m | us-gaap:Assets |
| Current liabilities | At period end2021-09-30 | $2.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-09-30 | $17.4m | us-gaap:Liabilities |
| Long-term debt | At period end2021-09-30 | $15.9m | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2021-09-30 | $74.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001493152-21-027618. Last ingested by Listed: Nov 5, 2026, 20:37 ET. Listed shows no prices and gives no investment advice.